25 XP   0   0   10

Patrys Ltd
Buy, Hold or Sell?

Let's analyse Patrys together

PenkeI guess you are interested in Patrys Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Patrys Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Patrys Ltd

I send you an email if I find something interesting about Patrys Ltd.

Quick analysis of Patrys (30 sec.)










What can you expect buying and holding a share of Patrys? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.01
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-142.3%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.009 - A$0.01
How sure are you?
50%

1. Valuation of Patrys (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.04 - A$-0.02

Total Value Per Share

A$-0.04 - A$-0.02

2. Growth of Patrys (5 min.)




Is Patrys growing?

Current yearPrevious yearGrowGrow %
How rich?$4.3m$8.5m-$4.2m-96.4%

How much money is Patrys making?

Current yearPrevious yearGrowGrow %
Making money-$4.5m-$4.3m-$180.1k-4.0%
Net Profit Margin-247.6%-24,655.9%--

How much money comes from the company's main activities?

3. Financial Health of Patrys (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#769 / 1019

Most Revenue
#455 / 1019

Most Profit
#406 / 1019

Most Efficient
#663 / 1019

What can you expect buying and holding a share of Patrys? (5 min.)

Welcome investor! Patrys's management wants to use your money to grow the business. In return you get a share of Patrys.

What can you expect buying and holding a share of Patrys?

First you should know what it really means to hold a share of Patrys. And how you can make/lose money.

Speculation

The Price per Share of Patrys is A$0.009. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Patrys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Patrys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Patrys.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-24.4%0.00-24.4%0.00-23.4%0.00-14.6%0.00-14.3%
Usd Book Value Change Per Share0.00-22.8%0.00-22.8%0.004.8%0.00-0.3%0.00-1.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-22.8%0.00-22.8%0.004.8%0.00-0.3%0.00-1.4%
Usd Price Per Share0.01-0.01-0.01-0.02-0.01-
Price to Earnings Ratio-2.91--2.91--6.07--34.29--24.79-
Price-to-Total Gains Ratio-3.12--3.12-29.71-2,072.60-1,038.26-
Price to Book Ratio3.01-3.01-3.06-5.56-6.01-
Price-to-Total Gains Ratio-3.12--3.12-29.71-2,072.60-1,038.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0057636
Number of shares173502
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (173502 shares)-355.86-4.90
Gains per Year (173502 shares)-1,423.46-19.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1423-14330-20-30
20-2847-28560-39-50
30-4270-42790-59-70
40-5694-57020-78-90
50-7117-71250-98-110
60-8541-85480-118-130
70-9964-99710-137-150
80-11388-113940-157-170
90-12811-128170-176-190
100-14235-142400-196-210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.016.01.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%6.011.00.035.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%5.05.00.050.0%6.011.00.035.3%

Fundamentals of Patrys

About Patrys Ltd

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-04-02 21:57:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Patrys Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Patrys earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • A Net Profit Margin of -247.6% means that $-2.48 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Patrys Ltd:

  • The MRQ is -247.6%. The company is making a huge loss. -2
  • The TTM is -247.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-247.6%TTM-247.6%0.0%
TTM-247.6%YOY-24,655.9%+24,408.3%
TTM-247.6%5Y-7,422.6%+7,175.0%
5Y-7,422.6%10Y-4,836.6%-2,585.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-247.6%-197.2%-50.4%
TTM-247.6%-210.4%-37.2%
YOY-24,655.9%-279.3%-24,376.6%
5Y-7,422.6%-436.8%-6,985.8%
10Y-4,836.6%-599.3%-4,237.3%
1.1.2. Return on Assets

Shows how efficient Patrys is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • -93.8% Return on Assets means that Patrys generated $-0.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Patrys Ltd:

  • The MRQ is -93.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -93.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-93.8%TTM-93.8%0.0%
TTM-93.8%YOY-48.5%-45.3%
TTM-93.8%5Y-36.3%-57.6%
5Y-36.3%10Y-49.8%+13.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-93.8%-13.6%-80.2%
TTM-93.8%-12.9%-80.9%
YOY-48.5%-11.9%-36.6%
5Y-36.3%-14.2%-22.1%
10Y-49.8%-16.2%-33.6%
1.1.3. Return on Equity

Shows how efficient Patrys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • -103.3% Return on Equity means Patrys generated $-1.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Patrys Ltd:

  • The MRQ is -103.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -103.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-103.3%TTM-103.3%0.0%
TTM-103.3%YOY-50.5%-52.8%
TTM-103.3%5Y-39.3%-64.0%
5Y-39.3%10Y-57.2%+17.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.3%-17.0%-86.3%
TTM-103.3%-16.1%-87.2%
YOY-50.5%-15.4%-35.1%
5Y-39.3%-20.0%-19.3%
10Y-57.2%-21.1%-36.1%

1.2. Operating Efficiency of Patrys Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Patrys is operating .

  • Measures how much profit Patrys makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • An Operating Margin of -345.8% means the company generated $-3.46  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Patrys Ltd:

  • The MRQ is -345.8%. The company is operating very inefficient. -2
  • The TTM is -345.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-345.8%TTM-345.8%0.0%
TTM-345.8%YOY-41,362.6%+41,016.8%
TTM-345.8%5Y-18,253.6%+17,907.8%
5Y-18,253.6%10Y-10,227.5%-8,026.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-345.8%-286.1%-59.7%
TTM-345.8%-224.4%-121.4%
YOY-41,362.6%-288.4%-41,074.2%
5Y-18,253.6%-475.2%-17,778.4%
10Y-10,227.5%-624.7%-9,602.8%
1.2.2. Operating Ratio

Measures how efficient Patrys is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.46 means that the operating costs are $3.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Patrys Ltd:

  • The MRQ is 3.458. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.458. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.458TTM3.4580.000
TTM3.458YOY292.676-289.218
TTM3.4585Y143.291-139.833
5Y143.29110Y85.282+58.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4582.997+0.461
TTM3.4583.247+0.211
YOY292.6763.766+288.910
5Y143.2915.675+137.616
10Y85.2827.857+77.425

1.3. Liquidity of Patrys Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Patrys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.38 means the company has $10.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Patrys Ltd:

  • The MRQ is 10.379. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.379. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.379TTM10.3790.000
TTM10.379YOY24.921-14.542
TTM10.3795Y14.393-4.015
5Y14.39310Y10.430+3.963
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3793.930+6.449
TTM10.3794.251+6.128
YOY24.9215.436+19.485
5Y14.3936.045+8.348
10Y10.4306.363+4.067
1.3.2. Quick Ratio

Measures if Patrys is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • A Quick Ratio of 11.48 means the company can pay off $11.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Patrys Ltd:

  • The MRQ is 11.483. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.483. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.483TTM11.4830.000
TTM11.483YOY24.378-12.895
TTM11.4835Y16.024-4.541
5Y16.02410Y11.329+4.695
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4833.629+7.854
TTM11.4834.065+7.418
YOY24.3785.397+18.981
5Y16.0245.993+10.031
10Y11.3296.277+5.052

1.4. Solvency of Patrys Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Patrys assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Patrys to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Patrys assets are financed with 9.1% credit (debt) and the remaining percentage (100% - 9.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Patrys Ltd:

  • The MRQ is 0.091. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.091. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.091TTM0.0910.000
TTM0.091YOY0.039+0.052
TTM0.0915Y0.074+0.017
5Y0.07410Y0.109-0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0910.332-0.241
TTM0.0910.334-0.243
YOY0.0390.268-0.229
5Y0.0740.366-0.292
10Y0.1090.390-0.281
1.4.2. Debt to Equity Ratio

Measures if Patrys is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Patrys to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.0% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Patrys Ltd:

  • The MRQ is 0.100. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.100. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.100TTM0.1000.000
TTM0.100YOY0.040+0.060
TTM0.1005Y0.080+0.020
5Y0.08010Y0.124-0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1000.381-0.281
TTM0.1000.390-0.290
YOY0.0400.334-0.294
5Y0.0800.434-0.354
10Y0.1240.466-0.342

2. Market Valuation of Patrys Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Patrys generates.

  • Above 15 is considered overpriced but always compare Patrys to the Biotechnology industry mean.
  • A PE ratio of -2.91 means the investor is paying $-2.91 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Patrys Ltd:

  • The EOD is -2.622. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.914. Based on the earnings, the company is expensive. -2
  • The TTM is -2.914. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.622MRQ-2.914+0.291
MRQ-2.914TTM-2.9140.000
TTM-2.914YOY-6.069+3.155
TTM-2.9145Y-34.290+31.376
5Y-34.29010Y-24.792-9.497
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.622-2.315-0.307
MRQ-2.914-2.560-0.354
TTM-2.914-2.664-0.250
YOY-6.069-4.122-1.947
5Y-34.290-6.258-28.032
10Y-24.792-6.108-18.684
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Patrys Ltd:

  • The EOD is -3.204. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.560. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.560. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.204MRQ-3.560+0.356
MRQ-3.560TTM-3.5600.000
TTM-3.560YOY-4.740+1.180
TTM-3.5605Y-86.797+83.237
5Y-86.79710Y-52.082-34.715
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.204-3.067-0.137
MRQ-3.560-3.251-0.309
TTM-3.560-3.545-0.015
YOY-4.740-5.595+0.855
5Y-86.797-8.315-78.482
10Y-52.082-8.708-43.374
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Patrys is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.01 means the investor is paying $3.01 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Patrys Ltd:

  • The EOD is 2.708. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.009. Based on the equity, the company is fair priced.
  • The TTM is 3.009. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.708MRQ3.009-0.301
MRQ3.009TTM3.0090.000
TTM3.009YOY3.065-0.056
TTM3.0095Y5.559-2.550
5Y5.55910Y6.006-0.447
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7081.905+0.803
MRQ3.0092.111+0.898
TTM3.0092.095+0.914
YOY3.0652.836+0.229
5Y5.5593.443+2.116
10Y6.0063.794+2.212
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Patrys Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Patrys Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%0.001-576%0.000-99%0.000-94%
Book Value Per Share--0.0030.0030%0.007-49%0.004-23%0.004-8%
Current Ratio--10.37910.3790%24.921-58%14.393-28%10.4300%
Debt To Asset Ratio--0.0910.0910%0.039+135%0.074+24%0.109-16%
Debt To Equity Ratio--0.1000.1000%0.040+148%0.080+25%0.124-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.003-0.0030%-0.003-4%-0.002-40%-0.002-41%
Free Cash Flow Per Share---0.003-0.0030%-0.004+50%-0.002-27%-0.002-39%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.001-81%0.000-20487%0.001-362%
Gross Profit Margin--0.9860.9860%0.963+2%0.984+0%0.992-1%
Intrinsic Value_10Y_max---0.021--------
Intrinsic Value_10Y_min---0.042--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.006--------
Intrinsic Value_3Y_min---0.011--------
Intrinsic Value_5Y_max---0.010--------
Intrinsic Value_5Y_min---0.019--------
Market Cap18517049.856-11%20574499.84020574499.8400%41148999.680-50%50654418.606-59%47095030.134-56%
Net Profit Margin---2.476-2.4760%-246.559+9858%-74.226+2898%-48.366+1853%
Operating Margin---3.458-3.4580%-413.626+11862%-182.536+5179%-102.275+2858%
Operating Ratio--3.4583.4580%292.676-99%143.291-98%85.282-96%
Pb Ratio2.708-11%3.0093.0090%3.065-2%5.559-46%6.006-50%
Pe Ratio-2.622+10%-2.914-2.9140%-6.069+108%-34.290+1077%-24.792+751%
Price Per Share0.009-11%0.0100.0100%0.020-50%0.025-59%0.023-56%
Price To Free Cash Flow Ratio-3.204+10%-3.560-3.5600%-4.740+33%-86.797+2338%-52.082+1363%
Price To Total Gains Ratio-2.810+10%-3.122-3.1220%29.711-111%2072.603-100%1038.260-100%
Quick Ratio--11.48311.4830%24.378-53%16.024-28%11.329+1%
Return On Assets---0.938-0.9380%-0.485-48%-0.363-61%-0.498-47%
Return On Equity---1.033-1.0330%-0.505-51%-0.393-62%-0.572-45%
Total Gains Per Share---0.003-0.0030%0.001-576%0.000-99%0.000-94%
Usd Book Value--4378784.9514378784.9510%8598748.141-49%5697175.791-23%4769637.401-8%
Usd Book Value Change Per Share---0.002-0.0020%0.000-576%0.000-99%0.000-94%
Usd Book Value Per Share--0.0020.0020%0.004-49%0.003-23%0.002-8%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.0020%-0.002-4%-0.001-40%-0.001-41%
Usd Free Cash Flow---3700757.609-3700757.6090%-5559633.881+50%-2685855.531-27%-2260359.298-39%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.003+50%-0.001-27%-0.001-39%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.000-81%0.000-20487%0.001-362%
Usd Market Cap11858318.728-11%13175909.69813175909.6980%26351819.395-50%32439089.675-59%30159657.298-56%
Usd Price Per Share0.006-11%0.0060.0060%0.013-50%0.016-59%0.015-56%
Usd Profit---4522264.010-4522264.0100%-4342144.465-4%-2202924.256-51%-2407582.519-47%
Usd Revenue--1826361.8831826361.8830%17611.000+10271%379361.177+381%390522.196+368%
Usd Total Gains Per Share---0.002-0.0020%0.000-576%0.000-99%0.000-94%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+7 -2710Y+9 -25

4.2. Fundamental Score

Let's check the fundamental score of Patrys Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.622
Price to Book Ratio (EOD)Between0-12.708
Net Profit Margin (MRQ)Greater than0-2.476
Operating Margin (MRQ)Greater than0-3.458
Quick Ratio (MRQ)Greater than111.483
Current Ratio (MRQ)Greater than110.379
Debt to Asset Ratio (MRQ)Less than10.091
Debt to Equity Ratio (MRQ)Less than10.100
Return on Equity (MRQ)Greater than0.15-1.033
Return on Assets (MRQ)Greater than0.05-0.938
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Patrys Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.391
Ma 20Greater thanMa 500.009
Ma 50Greater thanMa 1000.009
Ma 100Greater thanMa 2000.009
OpenGreater thanClose0.010
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets7,524
Total Liabilities687
Total Stockholder Equity6,838
 As reported
Total Liabilities 687
Total Stockholder Equity+ 6,838
Total Assets = 7,524

Assets

Total Assets7,524
Total Current Assets7,129
Long-term Assets395
Total Current Assets
Cash And Cash Equivalents 3,046
Short-term Investments 1,000
Net Receivables 2,842
Other Current Assets 241
Total Current Assets  (as reported)7,129
Total Current Assets  (calculated)7,129
+/-0
Long-term Assets
Property Plant Equipment 2
Intangible Assets 394
Other Assets 0
Long-term Assets  (as reported)395
Long-term Assets  (calculated)395
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities687
Long-term Liabilities0
Total Stockholder Equity6,838
Total Current Liabilities
Accounts payable 290
Other Current Liabilities 396
Total Current Liabilities  (as reported)687
Total Current Liabilities  (calculated)687
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock85,730
Retained Earnings -81,119
Accumulated Other Comprehensive Income 2,227
Total Stockholder Equity (as reported)6,838
Total Stockholder Equity (calculated)6,838
+/-0
Other
Capital Stock85,730
Cash and Short Term Investments 4,046
Common Stock Shares Outstanding 2,055,402
Liabilities and Stockholders Equity 7,524
Net Debt -3,046
Net Invested Capital 6,838
Net Tangible Assets 6,444
Net Working Capital 6,442
Property Plant and Equipment Gross 2



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-30
> Total Assets 
819
23,858
19,177
16,307
14,846
13,362
11,854
14,814
4,773
4,259
3,159
7,973
7,934
5,376
12,892
13,970
7,524
7,52413,97012,8925,3767,9347,9733,1594,2594,77314,81411,85413,36214,84616,30719,17723,858819
   > Total Current Assets 
757
16,191
9,936
7,570
6,335
6,378
5,438
8,827
4,694
3,544
2,491
7,349
7,354
4,844
12,404
13,528
7,129
7,12913,52812,4044,8447,3547,3492,4913,5444,6948,8275,4386,3786,3357,5709,93616,191757
       Cash And Cash Equivalents 
753
15,234
9,596
6,810
6,203
6,189
5,232
8,644
4,647
3,215
1,911
4,605
6,474
3,981
6,917
7,818
3,046
3,0467,8186,9173,9816,4744,6051,9113,2154,6478,6445,2326,1896,2036,8109,59615,234753
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
650
2,000
0
4,000
4,000
2,004
1,000
1,0002,0044,0004,00002,0006500000000000
       Net Receivables 
4
201
117
681
44
36
52
74
13
259
501
644
741
680
1,277
3,411
2,842
2,8423,4111,27768074164450125913745236446811172014
   > Long-term Assets 
62
7,667
9,241
8,737
8,511
6,984
6,416
5,987
79
715
668
624
580
532
488
442
395
395442488532580624668715795,9876,4166,9848,5118,7379,2417,66762
       Property Plant Equipment 
62
641
830
676
476
376
287
251
79
6
4
6
6
4
4
4
2
244466467925128737647667683064162
       Intangible Assets 
3,561
4,167
8,411
8,061
8,035
6,608
6,129
5,736
0
709
664
619
574
529
484
439
394
39443948452957461966470905,7366,1296,6088,0358,0618,4114,1673,561
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000
> Total Liabilities 
2,356
882
1,460
1,074
1,381
916
1,081
2,379
802
620
496
682
637
498
850
543
687
6875438504986376824966208022,3791,0819161,3811,0741,4608822,356
   > Total Current Liabilities 
2,140
856
1,260
959
1,281
916
1,044
2,336
746
595
480
661
621
473
850
543
687
6875438504736216614805957462,3361,0449161,2819591,2608562,140
       Short-term Debt 
0
9
25
4
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000042590
       Accounts payable 
488
600
242
174
331
309
195
1,543
157
35
65
220
199
78
298
162
290
2901622987819922065351571,543195309331174242600488
       Other Current Liabilities 
618
247
993
782
950
607
850
793
589
560
415
440
422
395
552
381
396
396381552395422440415560589793850607950782993247618
   > Long-term Liabilities 
0
26
200
115
100
0
37
43
56
25
16
21
16
25
298
162
0
016229825162116255643370100115200260
> Total Stockholder Equity
819
22,976
17,718
15,233
13,465
12,446
10,773
12,434
3,970
3,638
2,663
7,291
7,296
4,878
12,042
13,427
6,838
6,83813,42712,0424,8787,2967,2912,6633,6383,97012,43410,77312,44613,46515,23317,71822,976819
   Common Stock
8,335
31,581
34,677
39,635
45,075
49,136
50,713
59,676
59,676
60,036
60,036
67,039
67,067
67,087
78,112
85,724
85,730
85,73085,72478,11267,08767,06767,03960,03660,03659,67659,67650,71349,13645,07539,63534,67731,5818,335
   Retained Earnings -81,119-74,296-67,518-63,461-60,724-60,336-57,891-56,903-56,103-47,711-41,230-37,701-32,592-25,170-17,635-8,973-7,516
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
469
397
506
518
589
954
-3,625
-10,594
-11,427
-4,611
-4,611-11,427-10,594-3,6259545895185063974690000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.